Chicago Equity Partners LLC acquired a new position in shares of Waters Co. (NYSE:WAT) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 1,460 shares of the medical instruments supplier’s stock, valued at approximately $275,000.
Other institutional investors also recently bought and sold shares of the company. Hamilton Point Investment Advisors LLC raised its stake in shares of Waters by 4.4% during the 4th quarter. Hamilton Point Investment Advisors LLC now owns 14,320 shares of the medical instruments supplier’s stock worth $2,701,000 after buying an additional 600 shares in the last quarter. Alps Advisors Inc. raised its stake in shares of Waters by 7.1% during the 4th quarter. Alps Advisors Inc. now owns 5,949 shares of the medical instruments supplier’s stock worth $1,122,000 after buying an additional 394 shares in the last quarter. Financial Gravity Companies Inc. purchased a new position in shares of Waters during the 4th quarter worth approximately $64,000. BB&T Securities LLC purchased a new position in shares of Waters during the 4th quarter worth approximately $497,000. Finally, Ballentine Partners LLC raised its stake in shares of Waters by 4.9% during the 4th quarter. Ballentine Partners LLC now owns 2,526 shares of the medical instruments supplier’s stock worth $476,000 after buying an additional 118 shares in the last quarter. 89.08% of the stock is owned by institutional investors.
NYSE WAT opened at $234.58 on Friday. Waters Co. has a 1-year low of $167.93 and a 1-year high of $235.85. The company has a market capitalization of $17.73 billion, a P/E ratio of 28.30, a PEG ratio of 2.32 and a beta of 1.17. The company has a quick ratio of 2.01, a current ratio of 2.26 and a debt-to-equity ratio of 0.61.
Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.64 by $0.23. Waters had a return on equity of 34.18% and a net margin of 24.54%. The firm had revenue of $715.00 million during the quarter, compared to the consensus estimate of $702.74 million. During the same period last year, the business posted $2.51 EPS. Waters’s quarterly revenue was up 4.0% on a year-over-year basis. On average, equities research analysts expect that Waters Co. will post 9.35 EPS for the current fiscal year.
A number of equities analysts have recently issued reports on the company. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $256.00 target price for the company in a research note on Wednesday, January 30th. Barclays reissued a “hold” rating and set a $200.00 target price on shares of Waters in a research note on Friday, January 25th. BTIG Research increased their target price on Waters to $260.00 and gave the stock a “buy” rating in a research note on Thursday, January 24th. Robert W. Baird downgraded Waters from an “outperform” rating to a “neutral” rating and increased their target price for the stock from $191.00 to $211.00 in a research note on Thursday, January 24th. Finally, TheStreet raised Waters from a “c+” rating to a “b” rating in a research note on Thursday, January 17th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $208.99.
In other Waters news, Director Michael J. Berendt sold 3,500 shares of the firm’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $184.74, for a total transaction of $646,590.00. Following the completion of the transaction, the director now owns 27,411 shares of the company’s stock, valued at $5,063,908.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Michael C. Harrington sold 22,400 shares of the firm’s stock in a transaction on Wednesday, February 13th. The stock was sold at an average price of $234.93, for a total value of $5,262,432.00. Following the transaction, the senior vice president now directly owns 22,400 shares of the company’s stock, valued at approximately $5,262,432. The disclosure for this sale can be found here. Insiders have sold 122,961 shares of company stock valued at $27,285,652 in the last three months. 0.98% of the stock is currently owned by company insiders.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Story: How do taxes affect a CDs total return?
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.